Abstract
SYSTEMIC LUPUS ERYTHEMATOSUS: PREVALENCE OF IMMUNOLOGICAL MARKERS AND EXPERIENCE OF THE NATIONAL REFERENCE LABORATORY OF THE SHEIKH KHALIFA INTERNATIONAL HOSPITAL
Youssef Saoudi Hassani*, Zineb Youssfi, Zineb Nossir, Badr Erraji, Nabil Lazrak, Abdelhamid Zrara
ABSTRACT
Systemic Lupus Erythematosus (SLE) is a serious and currently incurable autoimmune disease. With an insidious onset and unpredictable course, SLE is characterized by a variety of clinical manifestations, and a broad autoantibody profile that makes it a great diagnostic challenge, especially at a very early stage of the disease. The diagnosis of SLE is clinical, supported by serological tests. In addition, no isolated clinical or biological parameter can confirm the diagnosis, hence the interest of the classification criteria. Through a retrospective study conducted within the National Reference Laboratory (LNR) of the Cheikh Khalifa International University Hospital in Casablanca, from March 2017 to March 2022, taking into account the new classification criteria, the importance of an analysis biological was highlighted (diagnosis, monitoring and therapeutic choice).
[Full Text Article] [Download Certificate]WJPLS CITATION
All | Since 2019 | |
Citation | 422 | 322 |
h-index | 9 | 7 |
i10-index | 4 | 2 |
INDEXING
NEWS & UPDATION
BEST ARTICLE AWARDS
World Journal of Pharmaceutical and life sciences is giving Best Article Award in every Issue for Best Article and Issue Certificate of Appreciation to the Authors to promote research activity of scholar.
Best Article of current issue
Download Article : Click here